TRPM8: A Therapeutic Target for Neuroinflammatory Symptoms Induced by Severe Dry Eye Disease
Dry eye disease (DED) is commonly associated with ocular surface inflammation and pain. In this study, we evaluated the effectiveness of repeated instillations of transient receptor potential melastatin 8 (TRPM8) ion channel antagonist M8-B on a mouse model of severe DED induced by the excision of e...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/22/8756 |
_version_ | 1797547347790528512 |
---|---|
author | Darine Fakih Christophe Baudouin Annabelle Réaux-Le Goazigo Stéphane Mélik Parsadaniantz |
author_facet | Darine Fakih Christophe Baudouin Annabelle Réaux-Le Goazigo Stéphane Mélik Parsadaniantz |
author_sort | Darine Fakih |
collection | DOAJ |
description | Dry eye disease (DED) is commonly associated with ocular surface inflammation and pain. In this study, we evaluated the effectiveness of repeated instillations of transient receptor potential melastatin 8 (TRPM8) ion channel antagonist M8-B on a mouse model of severe DED induced by the excision of extra-orbital lacrimal and Harderian glands. M8-B was topically administered twice a day from day 7 until day 21 after surgery. Cold and mechanical corneal sensitivities and spontaneous ocular pain were monitored at day 21. Ongoing and cold-evoked ciliary nerve activities were next evaluated by electrophysiological multi-unit extracellular recording. Corneal inflammation and expression of genes related to neuropathic pain and inflammation were assessed in the trigeminal ganglion. We found that DED mice developed a cold allodynia consistent with higher TRPM8 mRNA expression in the trigeminal ganglion (TG). Chronic M8-B instillations markedly reversed both the corneal mechanical allodynia and spontaneous ocular pain commonly associated with persistent DED. M8-B instillations also diminished the sustained spontaneous and cold-evoked ciliary nerve activities observed in DED mice as well as inflammation in the cornea and TG. Overall, our study provides new insight into the effectiveness of TRPM8 blockade for alleviating corneal pain syndrome associated with severe DED, opening a new avenue for ocular pain management. |
first_indexed | 2024-03-10T14:43:00Z |
format | Article |
id | doaj.art-83768fac1bd542f5ac29929d51d46d7e |
institution | Directory Open Access Journal |
issn | 1661-6596 1422-0067 |
language | English |
last_indexed | 2024-03-10T14:43:00Z |
publishDate | 2020-11-01 |
publisher | MDPI AG |
record_format | Article |
series | International Journal of Molecular Sciences |
spelling | doaj.art-83768fac1bd542f5ac29929d51d46d7e2023-11-20T21:36:19ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672020-11-012122875610.3390/ijms21228756TRPM8: A Therapeutic Target for Neuroinflammatory Symptoms Induced by Severe Dry Eye DiseaseDarine Fakih0Christophe Baudouin1Annabelle Réaux-Le Goazigo2Stéphane Mélik Parsadaniantz3Sorbonne Université, INSERM, CNRS, Institut de la Vision, 17 rue Moreau, F-75012 Paris, FranceSorbonne Université, INSERM, CNRS, Institut de la Vision, 17 rue Moreau, F-75012 Paris, FranceSorbonne Université, INSERM, CNRS, Institut de la Vision, 17 rue Moreau, F-75012 Paris, FranceSorbonne Université, INSERM, CNRS, Institut de la Vision, 17 rue Moreau, F-75012 Paris, FranceDry eye disease (DED) is commonly associated with ocular surface inflammation and pain. In this study, we evaluated the effectiveness of repeated instillations of transient receptor potential melastatin 8 (TRPM8) ion channel antagonist M8-B on a mouse model of severe DED induced by the excision of extra-orbital lacrimal and Harderian glands. M8-B was topically administered twice a day from day 7 until day 21 after surgery. Cold and mechanical corneal sensitivities and spontaneous ocular pain were monitored at day 21. Ongoing and cold-evoked ciliary nerve activities were next evaluated by electrophysiological multi-unit extracellular recording. Corneal inflammation and expression of genes related to neuropathic pain and inflammation were assessed in the trigeminal ganglion. We found that DED mice developed a cold allodynia consistent with higher TRPM8 mRNA expression in the trigeminal ganglion (TG). Chronic M8-B instillations markedly reversed both the corneal mechanical allodynia and spontaneous ocular pain commonly associated with persistent DED. M8-B instillations also diminished the sustained spontaneous and cold-evoked ciliary nerve activities observed in DED mice as well as inflammation in the cornea and TG. Overall, our study provides new insight into the effectiveness of TRPM8 blockade for alleviating corneal pain syndrome associated with severe DED, opening a new avenue for ocular pain management.https://www.mdpi.com/1422-0067/21/22/8756corneaelectrophysiologyinflammationdry eyeTRPM8 antagonist |
spellingShingle | Darine Fakih Christophe Baudouin Annabelle Réaux-Le Goazigo Stéphane Mélik Parsadaniantz TRPM8: A Therapeutic Target for Neuroinflammatory Symptoms Induced by Severe Dry Eye Disease International Journal of Molecular Sciences cornea electrophysiology inflammation dry eye TRPM8 antagonist |
title | TRPM8: A Therapeutic Target for Neuroinflammatory Symptoms Induced by Severe Dry Eye Disease |
title_full | TRPM8: A Therapeutic Target for Neuroinflammatory Symptoms Induced by Severe Dry Eye Disease |
title_fullStr | TRPM8: A Therapeutic Target for Neuroinflammatory Symptoms Induced by Severe Dry Eye Disease |
title_full_unstemmed | TRPM8: A Therapeutic Target for Neuroinflammatory Symptoms Induced by Severe Dry Eye Disease |
title_short | TRPM8: A Therapeutic Target for Neuroinflammatory Symptoms Induced by Severe Dry Eye Disease |
title_sort | trpm8 a therapeutic target for neuroinflammatory symptoms induced by severe dry eye disease |
topic | cornea electrophysiology inflammation dry eye TRPM8 antagonist |
url | https://www.mdpi.com/1422-0067/21/22/8756 |
work_keys_str_mv | AT darinefakih trpm8atherapeutictargetforneuroinflammatorysymptomsinducedbyseveredryeyedisease AT christophebaudouin trpm8atherapeutictargetforneuroinflammatorysymptomsinducedbyseveredryeyedisease AT annabellereauxlegoazigo trpm8atherapeutictargetforneuroinflammatorysymptomsinducedbyseveredryeyedisease AT stephanemelikparsadaniantz trpm8atherapeutictargetforneuroinflammatorysymptomsinducedbyseveredryeyedisease |